
UPADACITINIB 30 mg (Upadoz) is a prescription medicine used to treat various inflammatory and autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, Crohn’s disease, and atopic dermatitis in eligible patients. It belongs to a class of medicines called Janus kinase (JAK) inhibitors and works by reducing immune-system activity that causes inflammation. It should be used only under the supervision of a healthcare professional.
| Generic name | UPADACITINIB |
| Strength | 30 mg |
| Manufacturer | MSN Laboratories |
| Package size | 30 Tablets |
| Used for | Rheumatoid arthritis, atopic dermatitis, and ulcerative colitis |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Upadacitinib 30 mg works by selectively blocking Janus kinase 1 (JAK1), an enzyme involved in immune-system signalling. By reducing the activity of inflammatory pathways, it decreases the production of substances that cause inflammation and helps control symptoms associated with autoimmune and inflammatory diseases.